Screening, prevention, and treatment of congenital cytomegalovirus

Obstetrics and Gynecology Clinics of North America

Volumn 41, Issue 4, 2014, Pages 593-599

  Johnson, Julie ^a   Anderson, Brenna ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

CMV diagnosis; CMV hyperimmune globulin; CMV prevention; Congenital infection; Cytomegalovirus

Indexed keywords

CYTOMEGALOVIRUS VACCINE; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RECOMBINANT CMV ENVELOPE GLYCOPROTEIN B VACCINE; UNCLASSIFIED DRUG; CYTOMEGALOVIRUS-SPECIFIC HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN;

ANTIBODY TITER; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; ECHOGRAPHY; HEARING IMPAIRMENT; HUMAN; HYGIENE; INFECTION PREVENTION; MENTAL DEFICIENCY; MICROCEPHALY; NEWBORN DEATH; PATIENT EDUCATION; POLYMERASE CHAIN REACTION; REVIEW; SEIZURE; SEROPREVALENCE; VACCINATION; VIRUS CULTURE; VISUAL IMPAIRMENT; ADULT; AMNION FLUID; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; INFANT; ISOLATION AND PURIFICATION; MALE; MASS SCREENING; NEWBORN; PASSIVE IMMUNIZATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; PREVENTION AND CONTROL; PROCEDURES; RISK REDUCTION; STANDARDS; VERTICAL TRANSMISSION; VIROLOGY;

ADULT; AMNIOTIC FLUID; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; HYGIENE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MASS SCREENING; PATIENT EDUCATION AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; RISK REDUCTION BEHAVIOR;

EID: 84912561161     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2014.08.005     Document Type: Review

References (34)

1. Kenneson A., Cannon M.J. Review and metanalysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007, 17:253-276.
2. Dollard S.C., Grosse S.D., Ross D.S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007, 17:355-363.
3. Colugnati F., Staras S., Dollard S.C., et al. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 2007, 7:71.
4. Cannon M.J., Davis K.F. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005, 5:70.
5. Fowler K.B., Stagno S., Pass R.F., et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. NEngl J Med 1992, 326:663-667.
6. Gaytant M.A., Steegers E.A., Semmekrot B.A., et al. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002, 57:245-256.
7. Stagno S., Pass R.F., Dworsky M.E., et al. Maternal cytomegalovirus and perinatal transmission. Clin Obstet Gynecol 1982, 25:563-576.
8. Ludwig A., Henge H. Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro Surveill 2009, 14:1-7.
9. Fowler K.B., Stagno S., Pass R.F. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 2003, 289:1008-1011.
10. Stagno S., Pass R.F., Cloud G., et al. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA 1986, 256:1904-1908.
11. Wang C., Zhang X., Bialek S., et al. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 2011, 52:e11.
12. Enders G., Daiminger A., Bader U., et al. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. JClin Virol 2011, 52(3):244-246.
13. Cannon M.J., Westbrook K., Levis D., et al. Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus. Prev Med 2012, 54:351-357.
14. Pass R.F., Hutto C., Ricks R., et al. Increased rate of cytomegalovirus infection among parents of children attending day-care centers. NEngl J Med 1986, 314:1414-1418.
15. Munro S.C., Hall B., Whybin L.R., et al. Diagnosis of and screening for cytomegalovirus infection in pregnant women. JClin Microbiol 2005, 43(9):4713.
16. Revello M.G., Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002, 15(4):680-715.
17. Maidji E., McDonagh S., Genbacer O., et al. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 2006, 168(4):1210-1226.
18. American College of Obstetricians and Gynecologists clinical management guidelines for obstetricians-gynecologists, perinatal viral and parasitic infections. Washington, DC: American College of Obstetricians and Gynecologists. ACOG Practice Bulletin- Number 20, September 2000, reaffirmed in 2013.
19. At risk patients. Available at: . Accessed May 14, 2014. http://www.cdc.gov/cmv/clinical/at-risk.html.
20. Clinical diagnosis and treatment. Available at: . Accessed May 30, 2014. http://www.cdc.gov/cmv/clinical/diagnosis-treatment.html.
21. Guerra B., Simonazzi G., Banfi A., et al. Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers. Am J Obstet Gynecol 2007, 196(3):221.e1-221.e6.
22. Lazzarotto T., Guerra B., Lanari M., et al. New advances in the diagnosis of congenital cytomegalovirus infection. JClin Virol 2008, 41:192-197.
23. Lazzarotto T., Spezzacatena P., Pradelli P., et al. Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin Diagn Lab Immunol 1997, 4:469-473.
24. Liesnard C., Donner C., Brancart F., et al. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol 2000, 95:881-888.
25. Azam A., Vial Y., Fawer C., et al. Prenatal diagnosis of congenital cytomegalovirus infection. Obstet Gynecol 2001, 97:443-448.
26. Guerra B., Simonazzi G., Puccetti C., et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008, 198:380.e1-380.e7.
27. Benoist G., Salomon L., Jacquemard F., et al. The prognostic value of ultrasound abnormalities and biologic parameters in blood of fetuses infected with cytomegalovirus. BJOG 2008, 115:823-829.
28. Pass R.F., Zhang C., Evans A., et al. Vaccine prevention of maternal cytomegalovirus infection. NEngl J Med 2009, 360:1191-1199.
29. Krause P., Bialek S., Boppana S., et al. Priorities for CMV vaccine development. Vaccine 2014, 32:4-10.
30. Ross D.S., Rasmussen S.A., Cannon M.J., et al. Obstetrician/gynecologists' knowledge, attitudes, and practices regarding prevention of infection in pregnancy. JWomens Health (Larchmt) 2009, 18(8):1187-1193.
31. Adler S.P., Finney J.W., Manganello A.M., et al. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. JPediatr 2004, 145(4):485-491.
32. Nigro G., Adler S.P., La Torre R., et al. Passive immunization during pregnancy for congenital cytomegalovirus infection. NEngl J Med 2005, 353:1350-1362.
33. Revello M., Lazzarotto T., Guerra B., et al. Arandomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. NEngl J Med 2014, 370:1316-1326.
34. Interim analysis of the Cytotec Phase III trial in congenital cytomegalovirus (CMV) infection shows clear indication of efficacy. Available at: . Accessed June 3, 2014. http://www.biotest.de/ww/en/pub/investor_relations/news/newsdetails.cfm?newsID=1025191.